WallStSmart
RIGL

Rigel Pharmaceuticals Inc

NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY

$29.22
-4.38% today

Updated 2026-04-29

Market cap
$564.75M
P/E ratio
1.57
P/S ratio
1.92x
EPS (TTM)
$19.48
Dividend yield
52W range
$17 – $52
Volume
0.4M

Rigel Pharmaceuticals Inc (RIGL) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-35.84M$-52.21M$-103.52M$-102.78M$46.74M$-69.38M$-85.19M$-86.06M$-69.75M$-23.41M$-75.89M$-77.56M$-58.83M$-41.51M$-52.19M$5.88M$-73.76M$-5.74M$31.47M$75.66M
Capital expenditures$913000.00$933000.00$2.51M$141000.00$3.56M$2.30M$3.38M$1.22M$413000.00$546000.00$804000.00$164000.00$1.11M$1.46M$1.26M$627000.00$450000.00$15.00M$396000.00$0.00
Depreciation
Stock-based comp$12.58M$11.69M$23.76M$13.44M$16.44M$13.17M$12.62M$7.17M$9.79M$7.40M$7.33M$5.99M$7.70M$9.12M$7.30M$9.49M$12.38M$8.81M$12.39M$12.71M
Free cash flow$-36.75M$-53.14M$-106.03M$-102.92M$43.18M$-71.68M$-88.57M$-87.28M$-70.17M$-23.96M$-76.69M$-77.72M$-59.93M$-42.97M$-53.45M$5.25M$-74.21M$-20.74M$31.07M$75.66M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$9.76M$14.85M$-12.63M$-5.65M$28.25M$-25.82M$20.66M$38.03M$-53.80M$7.85M$-11.48M$5.57M